Evidence map›Paper›PMID 38170752›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

HKDC1, a target of TFEB, is essential to maintain both mitochondrial and lysosomal homeostasis, preventing cellular senescence.

Mengying Cui, Koji Yamano, Kenichi Yamamoto, Hitomi Yamamoto-Imoto, Satoshi Minami, Takeshi Yamamoto, Sho Matsui, Tatsuya Kaminishi, Takayuki Shima, Monami Ogura and 12 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
17.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 2 countries.

Mengying CuiDepartment of Genetics, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Koji YamanoUbiquitin Project, Tokyo Metropolitan Institute of Medical Science, Setagaya, Tokyo 156-8506, Japan.ORCID 0000-0002-4692-161X
Kenichi YamamotoDepartment of Statistical Genetics, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.ORCID 0000-0001-9594-7050
Hitomi Yamamoto-ImotoDepartment of Genetics, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Satoshi MinamiDepartment of Genetics, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.ORCID 0000-0001-5043-3435
Takeshi YamamotoDepartment of Nephrology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Sho MatsuiDepartment of Nephrology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Tatsuya KaminishiDepartment of Genetics, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.ORCID 0000-0001-5056-1074
Takayuki ShimaDepartment of Biochemistry, Nara Medical University, Kashihara, Nara 634-8521, Japan.
Monami OguraDepartment of Intracellular Membrane Dynamics, Graduate School of Frontier Biosciences, Osaka University, Suita, Osaka 565-0871, Japan.
Megumi TsuchiyaLaboratory of Nuclear Dynamics Group, Graduate School of Frontier Biosciences, Osaka University, Suita, Osaka 565-0871, Japan.
Kohei NishinoDivision of Cell Signaling, Fujii Memorial Institute of Medical Sciences, Institute of Advanced Medical Sciences, Tokushima University, Tokushima 770-8503, Japan.
Brian T LaydenDivision of Endocrinology, Diabetes, and Metabolism, University of Illinois Chicago, Chicago, IL 60612.
Hisakazu KatoDepartment of Medical Biochemistry, Graduate School of Medicine/Frontier Bioscience, Osaka University, Suita, Osaka 565-0871, Japan.ORCID 0000-0003-4619-3680
Hidesato OgawaLaboratory of Nuclear Dynamics Group, Graduate School of Frontier Biosciences, Osaka University, Suita, Osaka 565-0871, Japan.
Shinya OkiDepartment of Drug Discovery Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Yukinori OkadaDepartment of Statistical Genetics, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Yoshitaka IsakaDepartment of Nephrology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.ORCID 0000-0002-0820-7167
Hidetaka KosakoDivision of Cell Signaling, Fujii Memorial Institute of Medical Sciences, Institute of Advanced Medical Sciences, Tokushima University, Tokushima 770-8503, Japan.ORCID 0000-0003-3228-6368
Noriyuki MatsudaUbiquitin Project, Tokyo Metropolitan Institute of Medical Science, Setagaya, Tokyo 156-8506, Japan.ORCID 0000-0001-8199-952X
Tamotsu YoshimoriDepartment of Genetics, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.ORCID 0000-0001-9787-3788
Shuhei NakamuraDepartment of Biochemistry, Nara Medical University, Kashihara, Nara 634-8521, Japan.ORCID 0000-0002-1488-8317
The University of Osaka · JPNara Medical University · JPTokushima University · JPTokyo Medical and Dental University · JPKyoto University · JPOsaka International University · JPUniversity of Illinois Chicago · US

Funding

Training program in the biology and translational research on Alzheimer's diseaseand related dementiasT32AG057468 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Stephanie M Cologna, Orly Lazarov · 2017 to 2026
$2.3M
Acquisition of a Q-Exactive HF Mass SpectrometerS10OD027016 · OD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI COLOGNA, STEPHANIE M · 2019 to 2019
$600k
Astellas Foundation for Research on Metabolic Disorders N/AChina Scholarship Council (CSC) N/AJapan Agency for Medical Research and Development (AMED) 23jm0610091h0001Japan Agency for Medical Research and Development (AMED) JP22gm1410014MEXT | Japan Society for the Promotion of Science (JSPS) 21H02428MEXT | Japan Society for the Promotion of Science (JSPS) 22H04982MEXT | Japan Society for the Promotion of Science (JSPS) 23K18140MEXT | JST | Core Research for Evolutional Science and Technology (CREST) JPMJCR17H6Ministry of Education, Culture, Sports, Science and Technology (MEXT) 21H05145Mitsubishi Foundation (The Mitsubishi Foundation) N/AMochida Memorial Foundation for Medical and Pharmaceutical Research ( ) N/ANIA NIH HHS T32 AG057468NIH HHS S10 OD027016NOVARTIS Foundation (Japan) for the Promotion of Science (NOVARTIS Foundation (Japan)) N/ATakeda Science Foundation (TSF) N/A
6 · The paper itself

Abstract

Mitochondrial and lysosomal functions are intimately linked and are critical for cellular homeostasis, as evidenced by the fact that cellular senescence, aging, and multiple prominent diseases are associated with concomitant dysfunction of both organelles. However, it is not well understood how the two important organelles are regulated. Transcription factor EB (TFEB) is the master regulator of lysosomal function and is also implicated in regulating mitochondrial function; however, the mechanism underlying the maintenance of both organelles remains to be fully elucidated. Here, by comprehensive transcriptome analysis and subsequent chromatin immunoprecipitation-qPCR, we identified hexokinase domain containing 1 (HKDC1), which is known to function in the glycolysis pathway as a direct TFEB target. Moreover, HKDC1 was upregulated in both mitochondrial and lysosomal stress in a TFEB-dependent manner, and its function was critical for the maintenance of both organelles under stress conditions. Mechanistically, the TFEB-HKDC1 axis was essential for PINK1 (PTEN-induced kinase 1)/Parkin-dependent mitophagy via its initial step, PINK1 stabilization. In addition, the functions of HKDC1 and voltage-dependent anion channels, with which HKDC1 interacts, were essential for the clearance of damaged lysosomes and maintaining mitochondria-lysosome contact. Interestingly, HKDC1 regulated mitophagy and lysosomal repair independently of its prospective function in glycolysis. Furthermore, loss function of HKDC1 accelerated DNA damage-induced cellular senescence with the accumulation of hyperfused mitochondria and damaged lysosomes. Our results show that HKDC1, a factor downstream of TFEB, maintains both mitochondrial and lysosomal homeostasis, which is critical to prevent cellular senescence.

Indexed as

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsHexokinaseAutophagyCellular SenescenceHomeostasisLysosomesMitochondriaProspective StudiesProtein KinasesBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsHexokinaseProtein Kinasescellular senescenceHKDC1mitochondria–lysosome contactmitophagyTFEB

Identifiers

PMID38170752
PMCPMC10786298
OpenAlexW4390533754

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.